# Vertex Pharmaceuticals Inc / Ma: Form 8-K, filed Feb 12, 2018

- Company: [Vertex Pharmaceuticals Inc / Ma](/companies/vrtx.md) (CIK 875320)
- Form: 8-K
- Filed: 2018-02-12
- Accepted by EDGAR: Feb 12, 2018, 22:01 ET
- Period: 2018-02-12
- Accession: 0000875320-18-000005
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/875320/000087532018000005/a8-ktezapproval.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/875320/000087532018000005/

## Items reported

- Item 7.01: Regulation FD disclosure

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/875320/000087532018000005/a8-ktezapproval.htm

Filed Feb 12, 2018.
Source: SEC EDGAR, the filing index for accession 0000875320-18-000005. Last ingested by Listed: Nov 6, 2026, 12:56 ET. No prices; not investment advice.